Key statistics
As of last trade Alkermes Plc (8AK:FRA) traded at 26.20, -12.08% below its 52-week high of 29.80, set on Feb 16, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 26.20 |
---|---|
High | 26.20 |
Low | 26.20 |
Bid | 26.20 |
Offer | 27.00 |
Previous close | 26.20 |
Average volume | 115.56 |
---|---|
Shares outstanding | 161.80m |
Free float | 159.67m |
P/E (TTM) | 9.39 |
Market cap | 4.48bn USD |
EPS (TTM) | 2.95 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 07:11 GMT.
More ▼
Press releases
- Alkermes to Participate in Two Upcoming Investor Conferences
- Alkermes Highlights Presentations From Across Neuroscience Portfolio at Key Fall 2024 Scientific Conferences
- Alkermes plc Reports Third Quarter 2024 Financial Results
- Alkermes to Report Third Quarter Financial Results on October 24, 2024
- Alkermes to Host Investor Event to Review Orexin Portfolio Strategy
- Alkermes to Present Positive Clinical Data From Phase 1b Study of ALKS 2680 in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia at Sleep Europe 2024
- Alkermes to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Conference
- Alkermes Announces Launch of 7th Annual Alkermes Pathways Research Awards® Program
- Alkermes to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
More ▼